BeOne Medicines Ltd. Accounts Receivable, Credit Loss Expense (Reversal)
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2023-05-04
- BeOne Medicines Ltd. accounts receivable, credit loss expense (reversal) for the quarter ending 2023-03-31 was $222.00K.
- BeOne Medicines Ltd. accounts receivable, credit loss expense (reversal) for the quarter ending 2022-12-31 was -$58.00K, a 118.35% decline year-over-year.
- BeOne Medicines Ltd. accounts receivable, credit loss expense (reversal) for the quarter ending 2022-09-30 was $49.00K, a 25.64% increase year-over-year.
- BeOne Medicines Ltd. accounts receivable, credit loss expense (reversal) for the quarter ending 2022-06-30 was $31.00K.
- BeOne Medicines Ltd. accounts receivable, credit loss expense (reversal) for fiscal 2022 was -$219.00K, a 170.87% decline from fiscal 2021.
- BeOne Medicines Ltd. accounts receivable, credit loss expense (reversal) for fiscal 2021 was $309.00K, a 183.49% increase from fiscal 2020.
- BeOne Medicines Ltd. accounts receivable, credit loss expense (reversal) for fiscal 2020 was $109.00K.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|---|---|---|
| 2023-03-31 | $222.00K 10-Q · filed 2023-05-04 | $164.00K derived: sum of 2 quarters · filed 2023-05-04 | $213.00K derived: sum of 3 quarters · filed 2023-05-04 | $244.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | -$58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$9.00K derived: sum of 2 quarters · filed 2023-02-27 | $22.00K derived: sum of 3 quarters · filed 2023-02-27 | -$219.00K 10-K · filed 2023-02-27 |
| 2022-09-30 | $49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $80.00K derived: sum of 2 quarters · filed 2022-11-09 | -$161.00K 10-Q · filed 2022-11-09 | $155.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$210.00K 10-Q · filed 2022-08-08 | $106.00K derived: sum of 3 quarters · filed 2023-05-04 | $145.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-03-31 | -$241.00K 10-Q · filed 2023-05-04 | $75.00K derived: sum of 2 quarters · filed 2023-05-04 | $114.00K derived: sum of 3 quarters · filed 2023-05-04 | $20.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $355.00K derived: sum of 2 quarters · filed 2023-02-27 | $261.00K derived: sum of 3 quarters · filed 2023-02-27 | $309.00K 10-K · filed 2023-02-27 |
| 2021-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$55.00K derived: sum of 2 quarters · filed 2022-11-09 | -$7.00K 10-Q · filed 2022-11-09 | -$12.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | -$94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$46.00K 10-Q · filed 2022-08-08 | -$51.00K derived: sum of 3 quarters · filed 2023-02-27 | -$58.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $48.00K 10-Q · filed 2022-05-09 | $43.00K derived: sum of 2 quarters · filed 2023-02-27 | $36.00K derived: sum of 3 quarters · filed 2023-02-27 | -$1.86M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$12.00K derived: sum of 2 quarters · filed 2023-02-27 | -$1.91M derived: sum of 3 quarters · filed 2023-02-27 | $109.00K 10-K · filed 2023-02-27 |
| 2020-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$1.91M derived: sum of 2 quarters · filed 2021-11-04 | $114.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $121.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $2.02M 10-Q · filed 2021-05-06 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 |